Now a part of Trade and Channel Strategies
December 10-12, 2024W Hotel | Philadelphia, PAkeyboard_arrow_right
Search keyboard_arrow_right
keyboard_arrow_left Hide
DAY 3 ✦ Wednesday, August 16 - EST/EDT (Eastern Daylight, GMT-4)
search
DAY 3 ✦ Wednesday, August 16 - EST/EDT (Eastern Daylight, GMT-4)
search
Showing 1 of 1 Streams
General
8:45am - 9:15am
Breakfast, Coffee and Registration
9:15am - 9:30am
Co-Chair's Opening Remarks and Review of Day Two
- Matthew Malachowski, Pharm.D., MHA, BCPS - System Director, Population Health & Ambulatory Care Pharmacy, Ochsner Health Pharmacy
- Jerry Taglianetti - Senior Director, Biosimilar Strategic Marketing Team Lead, Amneal Pharmaceuticals
9:30am - 10:30am
Manufacturer and Integrated Delivery Network Collaboration
- Collaborative & co-creation of innovative solutions to improve patient outcomes:
- Legal and compliance perspective/challenges
- Resourcing of projects
- Stakeholder involvement – Internal & External
- Length of time with interventions and metric management – do long projects pay off?
- Operational Pathway development and considerations to optimize access, distribution and reimbursement of drugs, especially in the newly emerging buy and bill HCP administered medications
- Sheri Trutwin - Head of Strategic Accounts, Alnylam Pharmaceuticals
- Mahesh Tawney - Senior Director - Medical Outcomes Science Liasons, Alnylam Pharmaceuticals
- Jen Donovan - Co-Chair of the HOSP Health Economics, Research, and Outcomes Committee, HOSP Alliance
- Tanya Menchi - Officer on the HOSP Board of Directors, HOSP Alliance
- Stephen Cieplik - Health System Director, Alnylam Pharmaceuticals
10:30am - 11:05am
Morning Networking and Refreshment Break
11:05am - 11:50am
Using the blockchain network to enhance health system-to-supplier contract alignment
Learn how health systems avoid claims rework on the blockchain network
Learn how the current cumbersome and opaque process creates lengthy claims reprocessing work and cashflow issues
Hear the current challenges surrounding contract alignment using emails and EDI processes.
Hear an overview of how the blockchain network solves these issues by identifying price discrepancies at the beginning of the purchasing process
Hear how several major pharma manufacturers, wholesalers, and GPO’s are using blockchain to avoid revenue leakage and gain gain from real-time data alignment with trading partners
- Matthew Perron - Director of Pharma & Health System Partnerships, Chronicled, LLC
11:50am - 12:30pm
Confessions of a Manufacturer turned Health System employee
How the rise of specialty pharmacy has brought opportunities and challenges for all stakeholders involved in specialty patient care coordination and outcomes.
- The evolution of the Health System Integrated Specialty Pharmacy Service Offering brought about the deconstruction of the traditional SP model.
- Building the Health System Specialty Pharmacy Service Brand – both Internally and Externally.
- Realizing the commonalities in stakeholder shared missions and transforming specialty population health through strategic alliances.”
- John Robicsek - Assistant Vice President, Department of Pharmacy Services, Atrium Health
12:30pm - 1:25pm
Networking Lunch in the Exhibit Hall
1:25pm - 2:05pm
Artificial Intelligence (AI): Understanding AI's Capabilities and the Future of Healthcare
- AI’s ability to analyze vast amount of data sets and what it means for the industry:
- Faster and more efficient results for patients (turnaround time)
- Provides info for labs on patient medical history
- Present AI’s ability to help clinical trial side AND patient care
- Sophia Humphreys, PharmD, MHA, BCBBS - Director of System Pharmacy, Formulary Management, and Clinical Programs, Sutter Health
- Ira Klein - Vice President of Medical Affairs and Payer Relations, Tempus Labs
2:05pm - 2:50pm
Navigating the Future of Biosimilars
- What biosimilars will mean for the future of market access and patient care
- How will they disrupt drug costs
- Affects to supply chain
- Importance of and strategies for patient drug education
- Chad Pettit - Executive Director, Marketing, Global Biosimilars Commercial Lead, Amgen
- Sophia Humphreys, PharmD, MHA, BCBBS - Director of System Pharmacy, Formulary Management, and Clinical Programs, Sutter Health
- Joe Fuhr - Professor Emeritus of Economics, Widener University
2:50pm - 3:05pm
Final Remarks and Close of Conference
- Matthew Malachowski, Pharm.D., MHA, BCPS - System Director, Population Health & Ambulatory Care Pharmacy, Ochsner Health Pharmacy
- Jerry Taglianetti - Senior Director, Biosimilar Strategic Marketing Team Lead, Amneal Pharmaceuticals